BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2778115)

  • 1. Papillary mesenchymal bodies: a histologic finding useful in differentiating trichoepitheliomas from basal cell carcinomas.
    Brooke JD; Fitzpatrick JE; Golitz LE
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):523-8. PubMed ID: 2778115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
    Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
    Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inguinal keratotic Basal cell carcinoma mimicking giant solitary trichoepithelioma.
    Sahin MT; Demir MA; Kaya Y; Can M; Inanir I; Oztürkcan S
    J Dermatol; 2003 May; 30(5):395-9. PubMed ID: 12773805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the peritumoral stroma of basal cell carcinoma recapitulate the follicular connective tissue sheath?
    Sellheyer K; Krahl D
    J Cutan Pathol; 2011 Jul; 38(7):551-9. PubMed ID: 21366662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichoepithelioma: a 19-year clinicopathologic re-evaluation.
    Bettencourt MS; Prieto VG; Shea CR
    J Cutan Pathol; 1999 Sep; 26(8):398-404. PubMed ID: 10551412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of basal cell carcinoma among multiple trichoepitheliomas.
    Johnson SC; Bennett RG
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 2):322-6. PubMed ID: 8436650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.
    Abbas O; Richards JE; Mahalingam M
    Mod Pathol; 2010 Nov; 23(11):1535-43. PubMed ID: 20711172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic Mimics of Basal Cell Carcinoma.
    Stanoszek LM; Wang GY; Harms PW
    Arch Pathol Lab Med; 2017 Nov; 141(11):1490-1502. PubMed ID: 29072946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immature trichoepithelioma: report of six cases.
    Long SA; Hurt MA; Santa Cruz DJ
    J Cutan Pathol; 1988 Dec; 15(6):353-8. PubMed ID: 3220993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas.
    Basarab T; Orchard G; Russell-Jones R
    Am J Dermatopathol; 1998 Oct; 20(5):448-52. PubMed ID: 9790103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of drebrin, an actin binding protein, in basal cell carcinoma, trichoblastoma and trichoepithelioma.
    Mizutani Y; Iwamoto I; Kanoh H; Seishima M; Nagata K
    Histol Histopathol; 2014 Jun; 29(6):757-66. PubMed ID: 24346822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p27kip1 in basal cell carcinomas and trichoepitheliomas.
    Cesinaro AM; Migaldi M; Corrado S; Maiorana A
    Am J Dermatopathol; 2002 Aug; 24(4):313-8. PubMed ID: 12142610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
    Kirchmann TT; Prieto VG; Smoller BR
    Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermoscopy in the diagnosis and management of basal cell carcinoma.
    Lallas A; Apalla Z; Ioannides D; Argenziano G; Castagnetti F; Moscarella E; Longo C; Palmieri T; Ramundo D; Zalaudek I
    Future Oncol; 2015 Nov; 11(22):2975-84. PubMed ID: 26450622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
    Choi CW; Park HS; Kim YK; Lee SH; Cho KH
    J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria for histologic differentiation of desmoplastic trichoepithelioma (sclerosing epithelial hamartoma) from morphea-like basal-cell carcinoma.
    Takei Y; Fukushiro S; Ackerman AB
    Am J Dermatopathol; 1985 Jun; 7(3):207-21. PubMed ID: 4051130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichoepithelioma Misdiagnosed as Basal Cell Carcinoma.
    Kang KJ; Seo BF; Shin J; Kwon H; Byeon JH; Jung SN
    J Craniofac Surg; 2019; 30(3):e197-e199. PubMed ID: 30394977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
    Sellheyer K; Nelson P
    J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.